<DOC>
	<DOCNO>NCT00520104</DOCNO>
	<brief_summary>This open label , single-center study determine whether certain nasal medication interact PMI-150 ( intranasal ketamine ) 30 mg healthy adult volunteer patient allergic rhinitis .</brief_summary>
	<brief_title>Determination Drug Interactions Certain Nasal Medications With Intranasal Ketamine</brief_title>
	<detailed_description>To assess separately effect nasal vasoconstrictor ( oxymetazoline ) nasal steroid rate extent intranasal absorption PMI-150 30 mg .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Healthy adult Patients Allergic Rhinitis Under age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>